-
Hu Jinglin wrote, clear "14th Five-Year Plan" health care priorities!
Time of Update: 2021-03-21
Standardize the handling of service behaviors, make it convenient for the masses to seek medical treatment in different places, improve the accessibility of high-quality medical services, support the free flow of labor, and basically solve the problem of "advance" and reimbursement for hospitalization of patients in different places across provinces, benefiting 7.
-
The procurement of traditional Chinese medicine decoction pieces is not easy, and the concentration of decoction pieces enterprises will increase!
Time of Update: 2021-03-21
The concentration of Chinese herbal medicine enterprises will increase Purchasing Chinese herbal medicine pieces from hospitals requires the company's sales, the number of operating varieties, storage area, and delivery to designated locations within the specified time.
-
Top10, the world's most expensive drug, in 2021
Time of Update: 2021-03-21
The price of Myalept increased from US$71,306 per month to US$74,159 in February of this year, at an annual cost of nearly US$890,000.
At each stage, patients need to use different amounts of drugs, but usually about 168 bottles are used each year.
-
An inventory of the progress of new antiviral drugs for chronic hepatitis B
Time of Update: 2021-03-21
73 log10 IU/mL, respectively; the combined treatment group and the entecavir single-agent group, the mean values of HBsAg decline were 0.
-
The 14th Five-Year Plan released the most attention from the medical industry!
Time of Update: 2021-03-21
Medical Network News on March 15 The "Planning Outline" is a general roadmap for my country's development in the next 5 to 15 years, which points out the direction and goals for the next stage of dev
-
State Council: The latest news of the national consumables collection is announced
Time of Update: 2021-03-21
Medical Network News on March 15 More high-value consumables are included in centralized procurement On the evening of March 9, according to the official website of the State Council, Hu Jinglin, director of the National Medical Insurance Administration, published an article in the "Study Times" stating that we must overcome difficulties, find a fulcrum, and lead the medical reform to deepen with the "small incision and big reform" of medical insurance.
-
Orphan Drug Weekly | Selective IL-2 agonists and other 4 research therapies are shortlisted
Time of Update: 2021-03-21
Drug: Nemvaleukin alfaR&D company: AlkermesTreatment of disease: mucosal melanoma (mucosal melanoma)Introduction: Nemvaleukin alfa is an innovative engineering fusion protein under research, which is composed of modified interleukin-2 (IL-2) and a high-affinity IL-2α receptor chain, designed to selectively amplify tumor-killing effects Immune cells, while avoiding activating immunosuppressive cells.
-
Well-known pharmaceutical companies are informed of fiscal and taxation issues, fiscal and tax compliance is the focus of supervision
Time of Update: 2021-03-21
Regarding the issue of drug rebates under gold sales, the relevant person in charge of the Price Recruitment Department of the National Medical Insurance Bureau stated that according to the statistics of publicly available court judgments, more than half of the 100 compulsory drug companies nationwide from 2016 to 2019 were It was verified that there were direct or indirect acts of giving kickbacks.
-
Mindray and Jointown announced their joint involvement in IVD business, orthopedics...
Time of Update: 2021-03-21
The leaders of Jointown Medical Devices Group include: Chairman Gong Yihua, General Manager Fu Xiong, Senior Deputy General Manager Sun Yanbing, IVD Business Development Division Director Mr.
-
When will the net profit of unprofitable pharmaceutical companies such as Junshi and Consino turn positive?
Time of Update: 2021-03-19
5;">2021，1，，，、，？5;">。5;">202134，-U2020，，，2021，ADC。5;">“”，2021“”，：，？5;">，127《》：41“，。5;">01 ？5;">As of January 31, 2021, there are 7 biomedical companies listed on the fifth set of standards on the Science and Technology Innovation Board, namely Zejing Pharmaceutical, Biotech, Shenzhou Cell, Junshi Bio, Kangsino, Frontier Bio and Iris.
-
The teams of Chen Wei and Zhong Nanshan have deployed new vaccine research and development
Time of Update: 2021-03-18
Recently, a reporter from Science and Technology Daily learned during the two sessions that the team of Academician Chen Wei and Academician Zhong Nanshan have separately deployed the research and development of new vaccines.
-
Health Commission: 7 new confirmed cases, all imported cases
Time of Update: 2021-03-18
As of 24:00 on March 12, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 184 confirmed cases (no severe cases), 85,214 cured and discharged cases, and 4,636 deaths.
-
Irma completes $130 million B round of financing
Time of Update: 2021-03-18
Stora has more than 25 years of venture capital experience in China, and has invested in more than 110 companies in the fields of healthcare and technological innovation.
-
Experts call on the public to actively vaccinate the new crown vaccine to build a herd immune barrier
Time of Update: 2021-03-18
Eligible public vaccination forms a herd immune barrier.
He appealed to the public who meet the conditions to actively cooperate with the vaccination.
(Reporters Peng Yunjia and Wang Linlin)aspx?id=3570" target="_blank" style="color:#ba1413">Focus on the new crown pneumonia epidemic
-
Can the adenovirus vector vaccine accelerate vaccination?
Time of Update: 2021-03-18
Wu Zunyou said A few days ago, according to the Beijing Municipal Center for Disease Control and Prevention, the new crown vaccine has gradually lifted the age limit for vaccination, and some elderly people aged 60 and above who have vaccination needs and have a good physical condition are vaccinated against new crown vaccine.
-
Health Commission: 10 newly diagnosed cases on the 3rd are all imported from abroad
Time of Update: 2021-03-18
As of 24:00 on March 3, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 177 confirmed cases (including 1 severe case), 85,130 cured and discharged cases, and 4,636 deaths.
-
Health Commission: 10 newly confirmed cases, all imported cases
Time of Update: 2021-03-18
As of 24:00 on March 13, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 183 confirmed cases (no severe cases), 85,225 cured and discharged cases, and 4,636 deaths.
-
WHO experts remind to pay attention to the long-term impact of the new crown
Time of Update: 2021-03-18
Kluger said at an online press conference held in Copenhagen that day that one in ten European patients with COVID-19 still had symptoms 12 weeks after healed, and many people’s symptoms would last longer, causing serious social, economic, and economic problems.
-
Sinopec established the Institute of Medical and Sanitary Materials
Time of Update: 2021-03-18
(Sina Pharmaceutical News )On March 3, the Information Office of Sinopec announced that the Beijing Research Institute of Chemical Industry, affiliated to Sinopec, officially established the Institute of Medical and Hygienic Materials on February 24.
-
Health Commission: 10 newly diagnosed cases on the 22nd, all imported from abroad
Time of Update: 2021-03-18
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on February 22 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on February
